The Centers for Medicare & Medicaid Services last week released a FAQ clarifying when the Clinical Laboratory Improvement Amendments apply to over-the-counter home tests, including COVID-19 tests. For example, tests that are cleared, approved or authorized for home use by the Food and Drug Administration generally are not regulated under CLIA when self-administered, but require a CLIA certificate when someone else performs, interprets or reports the results, the FAQ notes.

Related News Articles

Headline
The Department of Health and Human Services’ Administration for Strategic Preparedness and Response yesterday awarded $600 million for 12 domestic COVID-19…
Headline
AHA today participated in a Centers for Disease Control and Prevention Fall Immunization Kick-off Event for partner organizations, which focused on vaccinating…
Headline
AHA is providing its latest social media toolkit to help hospitals encourage vaccination against COVID-19. The newest toolkit includes messages and assets…
Headline
The Food and Drug Administration’s independent Nonprescription Drugs Advisory Committee Sept. 12 by unanimous vote declared oral phenylephrine…
Headline
As authorized yesterday by the Food and Drug Administration and recommended by its vaccine advisory committee, the Centers for Disease Control and Prevention…
Headline
Under the Department of Health and Human Services’ recent agreement with Regeneron to develop a new monoclonal antibody to prevent COVID-19, the U.S. list…